{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:38:25Z","timestamp":1758638305076},"reference-count":37,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T00:00:00Z","timestamp":1468713600000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Risk Analysis"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Over the past 50 years, the use of vaccines led to significant decreases in the global burdens of measles and rubella, motivated at least in part by the successive development of global control and elimination targets. The Global Vaccine Action Plan (GVAP) includes specific targets for regional elimination of measles and rubella in five of six regions of the World Health Organization by 2020. Achieving the GVAP measles and rubella goals will require significant immunization efforts and associated financial investments and political commitments. Planning and budgeting for these efforts can benefit from learning some important lessons from the Global Polio Eradication Initiative (GPEI). Following an overview of the global context of measles and rubella risks and discussion of lessons learned from the GPEI, we introduce the contents of the special issue on modeling and managing the risks of measles and rubella. This introduction describes the synthesis of the literature available to support evidence\u2010based model inputs to support the development of an integrated economic and dynamic disease transmission model to support global efforts to optimally manage these diseases globally using vaccines.<\/jats:p>","DOI":"10.1111\/risa.12655","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T14:20:37Z","timestamp":1468765237000},"page":"1288-1296","source":"Crossref","is-referenced-by-count":5,"title":["Modeling and Managing the Risks of Measles and Rubella: A Global Perspective, Part I"],"prefix":"10.1111","volume":"36","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[{"name":"Kid Risk, Inc  Orlando FL USA"},{"name":"College of Medicine University of Central Florida  Orlando FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Cochi","sequence":"additional","affiliation":[{"name":"Center for Global Health, Global Immunization Division Centers for Disease Control and Prevention (CDC)  Atlanta GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,7,17]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Decade of Vaccines. Global vaccine action plan. Available at:http:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/ Accessed 12 April 2015."},{"key":"e_1_2_6_3_1","unstructured":"World Health Organization. Global measles and rubella strategic plan 2012\u20132020. Available at:http:\/\/www.who.int\/immunization\/newsroom\/Measles_Rubella_StrategicPlan_2012_2020.pdf Accessed 11 May 2014."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000165"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12637"},{"key":"e_1_2_6_6_1","first-page":"352","volume-title":"Vaccines: Expert Consult","author":"Strebel PM","year":"2012"},{"key":"e_1_2_6_7_1","first-page":"35","article-title":"Congenital cataract following German measles in the mother","volume":"3","author":"Gregg NM","year":"1941","journal-title":"Transactions of the Ophthalmological Society of Australia"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12263"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92311-X"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182809dda"},{"key":"e_1_2_6_11_1","first-page":"419","volume-title":"Vaccines: Expert Consult","author":"Rubin SA","year":"2012"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00853.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12030"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/sdr.419"},{"key":"e_1_2_6_15_1","unstructured":"Measles & Rubella Initiative. The measles & rubella initiative 2013 annual report 2013."},{"key":"e_1_2_6_16_1","unstructured":"World Health Organization. Global Polio Eradication Initiative\u2014Financial resource requirements 2013\u20132018 as of 1 June 2013. Geneva 2013. Report No.: WHO\/POLIO\/13.01."},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60532-7"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.02.013"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit843"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491212700104"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12044"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.026"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir096"},{"key":"e_1_2_6_24_1","article-title":"Measles eradication versus measles control: An economic analysis","volume":"3","author":"Bishai D","year":"2012","journal-title":"Journal of Vaccines and Vaccination"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000164"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.058"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12331"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12264"},{"key":"e_1_2_6_29_1","unstructured":"World Bank. New country classifications World Bank income levels. Available at:http:\/\/data.worldbank.org\/news\/new-country-classifications Accessed 3 March 2014."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12459"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.091"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit843"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12440"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12424"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2715"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12454"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12430"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12264"}],"container-title":["Risk Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Frisa.12655","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/risa.12655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:47:43Z","timestamp":1694620063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/risa.12655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/risa.12655"],"URL":"https:\/\/doi.org\/10.1111\/risa.12655","archive":["Portico"],"relation":{},"ISSN":["0272-4332","1539-6924"],"issn-type":[{"value":"0272-4332","type":"print"},{"value":"1539-6924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}